Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Breast Neoplasms 27Neoplasms 25Lung Neoplasms 12Uterine Cervical Neoplasms 11Colorectal Neoplasms 10Colonic Neoplasms 8Motor Activity 7Urinary Bladder Neoplasms 6Rectal Neoplasms 6Vulvar Neoplasms 5Obesity 5Endometrial Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Melanoma 4Head and Neck Neoplasms 4Anxiety Disorders 4Stomach Neoplasms 3Sarcoma 3Prostatic Neoplasms 3Papillomavirus Infections 3Lymphoma 3Hematopoietic and Lymphoid System Neoplasm 3Hematologic Neoplasms 3Depression 3Carcinoma, Ovarian Epithelial 3Breast Carcinoma In Situ 3Vaginal Neoplasms 2Testicular Neoplasms 2Smoking Cessation 2Skin Neoplasms 2

Interventions

oxycodone-acetaminophen 1cyclohexaneacetic acid 1acetaminophen, hydrocodone drug combination 1Pain Management 1Methods 1Ibuprofen 1Gabapentin 1Fentanyl 1Educational Status 1Early Intervention, Educational 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Abnormalities, Radiation-Induced × Methods × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡